Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-005718

10% owner bought 5,000 shares at an average $15.16 ($75,800)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-03 Purchase : show line 1 in the form +3,000 $15.85 $47,550 4,774,794 D
2021-03-04 Purchase : show line 2 in the form +2,000 $14.13 $28,250 4,776,794 D
Open-market purchases · 5,000 sh · avg $15.16 · $75,800
Loading xslF345X03/doc1.xml…